Results From a Multi-Center Survey Among Physicians and Patients on the Acceptance of New Treatment Strategy With Third Generation of EGFR-TKI Plus Bispecific Antibody for Advanced EGFR-Mutant NSCLC

JTO Clinical and Research Reports · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles